ISSN: 0970-938X (Print) | 0976-1683 (Electronic)

Biomedical Research

An International Journal of Medical Sciences


Case Reports: Aripripazole Reduces Risperidone-Induced Hyperprolactinemia

Many schizophrenic patients treated with typical or atypical antipsychotics (AP) such as risperidone show significant clinical alterations as changes in sexual activity, menstrual cycle, amenorrhea, galattorrea and cardiovascular disorders because of AP-induced hyperprolactinemia. In the present paper we report two clinical cases showing, after switching with aripiprazole, a PRL normalization and a marked improvement of clinical events related to risperidone- induced hyperprolactinemia

Author(s): Walter Milano, Luca Milano, Claudio Petrella, Andrea Ingenito, Anna Capasso
Abstract | Full-Text | PDF

Share this  Facebook  Twitter  LinkedIn  Google+